Biomet Says DoJ Scales Down Antitrust Probe

Law360, New York (July 28, 2006, 12:00 AM EDT) -- Biomet Inc. became the latest orthopedic company to attempt to clear its name Friday, saying the Department of Justice’s current probe into the multi-billion dollar orthopedic industry had been narrowed to one specific incident.

According to the company, the DOJ’s antitrust investigation was prompted by an unsolicited e-mail that Biomet received from a competitor.

The e-mail, which proposed a unified pricing strategy for one hospital, was received by an independent Biomet distributor. However, it was never transmitted to Biomet, the company said, and neither Biomet nor...
To view the full article, register now.